Pricing Log in Create free account

Acurx Pharmaceuticals, Inc. (ACXP) vs Niki BioSolutions, Inc. (NIKI)

Acurx Pharmaceuticals, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and Niki BioSolutions, Inc. are of similar size ($6.9M and $6.5M). Acurx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Niki BioSolutions, Inc. leads on 5 and Acurx Pharmaceuticals, Inc. on 4.

Valuation

Metric ACXP NIKI Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.57 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.78 n/m 0.64
EV/Sales n/m 1.25 9.21
Earnings yield (244.55%) (330.05%) (33.15%)
Free cash flow yield (131.97%) 0.00% (25.50%)

Profitability

Metric ACXP NIKI Biotechnology median
Gross margin — (87.96%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (921.74%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (128.11%) 0.00% (56.36%)
Return on assets (87.57%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACXP NIKI Biotechnology median
Revenue growth (TTM) — 42.64% 6.02%
EPS growth (last fiscal year) 69.43% 75.64% 30.26%
Revenue growth, 5-year CAGR — 2.38% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACXP NIKI Biotechnology median
Debt to equity 0.00 0.25 0.00
Current ratio 3.88 0.78 4.72
Net debt to EBITDA 0.93 0.02 0.96

Dividend

Metric ACXP NIKI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACXP NIKI Biotechnology median
Market cap 6.50m 6.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack